1. Home
  2. PROF

as of 02-23-2026 3:54pm EST

$7.05
$0.11
-1.47%
Stocks Health Care Medical/Dental Instruments Nasdaq

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: MISSISSAUGA
Market Cap: 230.4M IPO Year: 2017
Target Price: $12.00 AVG Volume (30 days): 148.8K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 1.14 EPS Growth: -16.42
52 Week Low/High: $3.90 - $8.95 Next Earning Date: 01-01-0001
Revenue: $10,680,000 Revenue Growth: 48.35%
Revenue Growth (this year): 61.09% Revenue Growth (next year): 120.94%
P/E Ratio: 6.18 Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: